Breast ultrasound or mammography — which should you choose and when?

Medical author: Iwona Chruścicka, MD, PhD, general and oncological surgeon, specialist in the diagnosis and treatment of breast diseases — subject to approval before publication · Editorial preparation: Wyspa Medycyny Przyjaznej Editorial Team · Medical review: Iwona Chruścicka, MD, PhD — to be confirmed before publication · Review date: to be completed after approval · Publication: to be completed · Updated: 10 July 2026

This article is educational and does not replace a medical consultation. A new breast lump, skin or nipple retraction, bloody discharge, ulceration, enlarged axillary lymph nodes, or a BI-RADS 4–5 result requires further diagnostics and discussion with a doctor.

Key information at a glance

• Mammography is the primary screening test used in breast cancer prevention for women in the age group covered by the screening programme.
• Breast ultrasound is important in younger patients, in women with dense breasts, when a lump is palpable, in cystic lesions, and as a complementary examination.
• Ultrasound and mammography detect different features — mammography is particularly useful for identifying microcalcifications, while ultrasound helps determine whether a lesion is solid or fluid-filled.
• In Poland, the NFZ breast cancer screening programme includes mammography for women aged 45–74, usually every 24 months, provided they meet the programme criteria.
• If a patient can feel a lump, has bloody nipple discharge or a skin change on the breast, she should not wait for a screening examination — symptom-based diagnostics are required.
• BI-RADS is an imaging assessment category, not a final diagnosis. BI-RADS 4–5 usually means that a biopsy is needed, but it is not yet a histopathological result.
• From our clinical experience, a breast ultrasound report can be very frightening for a patient, but nothing is determined at the imaging stage alone. Only biopsy and histopathology provide a tissue diagnosis.
• Many biopsies confirm benign lesions, but they are performed precisely to avoid guessing and to prevent treatment delays if the lesion proves significant.
• A breast surgeon helps organise and interpret ultrasound, mammography, BI-RADS findings, indications for biopsy and the next steps in management.

Learn more about the specialist

Iwona Chruścicka, MD, PhD, is a general and oncological surgeon with experience in the diagnosis and treatment of breast diseases. At Wyspa Medycyny Przyjaznej, she is involved in interpreting ultrasound and mammography results, consulting breast lesions, performing breast tumour biopsies, assessing eligibility for surgical treatment and guiding patients through the subsequent stages of diagnostics.

Meet Iwona Chruścicka, MD, PhD

Does this topic make sense for SEO, AI and Google Search?

Yes. Patients very often search for answers to questions such as: “breast ultrasound or mammography”, “can ultrasound detect breast cancer”, “is mammography enough”, “breast ultrasound after 30”, “mammography after 40”, “dense breasts — ultrasound or mammography”, “BI-RADS 3 what next”, “BI-RADS 4 is it cancer”, “referred for biopsy after breast ultrasound”, and “does a breast biopsy mean cancer”. An educational article addresses these search intentions without cannibalising the service page about breast lumps or biopsy.

In oncology-related topics, E-E-A-T is particularly important: a named medical author, medical review, update date, sources, a description of warning symptoms, a clear distinction between screening and symptom-based diagnostics, and emphasis that an ultrasound or mammography image does not replace histopathology.

Breast ultrasound and mammography — why is this not an “either-or” choice?

Patients often ask: “which is better — breast ultrasound or mammography?”. In practice, this question is too simplistic. Mammography and breast ultrasound show breast tissue in different ways. Mammography uses X-rays and is particularly important in screening and in detecting certain changes, including microcalcifications. Ultrasound uses sound waves and is useful for assessing cysts, solid lesions, the structure of a lump and certain abnormalities in women with dense glandular tissue.

For this reason, the tests often complement one another. One patient may only need screening mammography, another may require ultrasound, and another may need mammography, ultrasound and biopsy. The correct pathway depends on age, symptoms, breast density, previous test results, family risk and the appearance of the specific lesion.

Mammography — when is it the first-choice examination?

Mammography is the primary screening test used in breast cancer prevention for women within the age range covered by the programme. Its purpose is to detect changes at an early stage, before they become palpable. In Poland, the breast cancer screening programme covers women aged 45–74, usually every 24 months, provided they meet the programme criteria.

Mammography is particularly important because it can identify changes that cannot be felt on examination, including microcalcifications. However, it is not a perfect test. In women with very dense breasts, mammographic sensitivity may be lower, so in selected situations a doctor may recommend ultrasound or another complementary examination.

Important: if a patient has a symptom — a lump, bloody discharge, nipple retraction or a skin change — this is no longer only a screening issue. A symptom requires diagnostics even if a recent screening mammogram was normal.

Breast ultrasound — when is it particularly useful?

Breast ultrasound is very useful in younger women, whose breast tissue is often more glandular and dense. It helps assess a palpable lump, distinguish a cyst from a solid lesion, monitor selected benign changes and complement diagnostics after mammography.

Ultrasound may be recommended when:

• the patient can feel a lump in the breast or armpit,
• mammography shows dense breasts or a lesion requiring further clarification,
• there is focal pain, asymmetry or local thickening,
• a cyst needs to be distinguished from a solid lesion,
• a known benign lesion requires follow-up,
• the doctor is planning an ultrasound-guided biopsy,
• the patient is young, pregnant or breastfeeding — imaging decisions then require an individual approach.

Ultrasound should not be treated as a simple substitute for screening mammography in women who qualify for the programme. It can, however, be a very important complementary or diagnostic examination.

“The ultrasound frightened me” — why is an imaging result not yet a verdict?

Our clinical experience shows that a breast ultrasound report can have a very negative psychological impact on a patient. Terms such as “solid lesion”, “suspicious”, “BI-RADS 4” or “biopsy recommended” may appear in the report. For the patient, this can sound like a confirmed diagnosis of cancer. At this stage, however, nothing has yet been determined.

Ultrasound or mammography shows the appearance of a lesion, but it does not definitively determine which cells it is made of. If a biopsy is recommended, it is done precisely to avoid guessing. Many biopsies confirm benign lesions, while if the result is more serious, prompt biopsy allows treatment to be planned efficiently.

The most important message for the patient is: do not ignore the result, but do not treat it as a verdict either. Between a “suspicious ultrasound image” and a “diagnosis of breast cancer”, there is still a key stage: biopsy and histopathological examination.

BI-RADS in ultrasound and mammography — what does it mean?

BI-RADS is a classification system used in breast imaging reports. It helps organise the result and indicate the next recommended step. It is not a histopathological diagnosis. BI-RADS describes how a lesion appears on imaging; it does not provide a final answer as to whether it is cancer.

The greatest anxiety is usually associated with BI-RADS 3, 4 and 5. BI-RADS 3 does not mean cancer, but it requires follow-up. BI-RADS 4 does not mean “definitely cancer”, but usually requires biopsy. BI-RADS 5 is highly suspicious, but the final diagnosis still requires tissue examination.

The ultrasound is normal, but I can feel a lump — what should I do?

If a patient can feel a lump but ultrasound or mammography does not explain the symptom, the result should be discussed with a doctor. Sometimes the examination needs to be repeated, performed at a different point in the menstrual cycle, compared with previous studies, or supplemented with mammography, targeted ultrasound, MRI or biopsy if the clinical symptom remains concerning.

A normal imaging result is usually reassuring, but it should not automatically end the diagnostic process if the patient continues to feel a lesion, notices skin or nipple retraction, bloody discharge or an enlarged axillary lymph node. Imaging must be interpreted together with the clinical examination.

The mammogram is normal, but ultrasound was recommended — does this mean something is wrong?

Not necessarily. Ultrasound may be used as a complementary examination, particularly in women with dense breasts, a palpable lump, focal pain, cysts or an area requiring clarification. An additional test does not always mean that cancer is suspected. It often simply means that the doctor or radiologist wants to assess a specific area more clearly.

Dense breast tissue can make mammography more difficult to interpret. In such cases, additional ultrasound may be a reasonable part of diagnostics, but the decision should depend on the entire clinical picture: age, mammography result, symptoms, family risk and physical examination.

When are patients referred to a breast surgeon after ultrasound or mammography?

A patient is usually referred to a breast surgeon when an imaging result requires interpretation, when a palpable tumour is present, when the radiologist recommends biopsy, or when the BI-RADS category indicates further diagnostics. A breast surgeon is not only a doctor who operates. Very often, the surgeon’s role is to organise the diagnostic pathway.

A breast surgeon consultation is particularly important when:

• the result is BI-RADS 4 or BI-RADS 5,
• the result is BI-RADS 0 and further diagnostics are required,
• the patient can feel a lump despite an inconclusive imaging result,
• the radiologist recommends biopsy,
• a core needle biopsy or discussion of its result is required,
• the histopathology result is unclear or requires further treatment,
• a benign lesion is growing, painful, troublesome or requires removal,
• the patient has a significant family history and needs a surveillance plan.

Biopsy after breast ultrasound — does it mean cancer?

No. A referral for biopsy means that the appearance of the lesion requires tissue verification. A biopsy is performed to avoid guessing. Some lesions that look suspicious on ultrasound or mammography prove to be benign, but this cannot be confirmed responsibly without examining tissue.

Core needle biopsy is most often used when breast cancer is suspected because it provides a tissue sample for histopathological examination. In selected situations, fine-needle aspiration may be used, for example for cystic lesions or cytological assessment. The doctor decides which method best answers the specific diagnostic question.

The biopsy result should be discussed with a doctor. If it confirms a benign lesion, observation or planned removal may be appropriate if the lesion causes symptoms. If cancer is confirmed, further treatment needs to be planned in the correct sequence.

Breast ultrasound before the age of 40 — does it make sense?

Yes, in many situations it does, particularly when the patient is young, has dense glandular tissue, feels a lump, has focal pain, a cyst, another concerning symptom, or requires follow-up of a known lesion. Ultrasound is often the first imaging test in younger symptomatic patients.

This does not mean that a woman over 40 or 45 should rely only on ultrasound. The importance of mammography increases with age, particularly as a screening examination. The decision should therefore be individual rather than based on a simplistic division of “younger women — ultrasound, older women — mammography”.

Mammography after the age of 45 — why should it not be postponed?

Screening mammography is valuable precisely because some breast cancers may remain asymptomatic for a period of time. A patient may not feel a lump, the breast may look normal, yet imaging may detect a lesion earlier than self-examination.

Under the NFZ programme, women aged 45–74 can receive free mammography. However, if a patient has symptoms or a significant family history, the diagnostic pathway may differ from routine screening and should be discussed with a doctor.

Symptoms that must not be ignored

Prompt medical consultation is particularly important in the case of:

• a new lump or thickening in the breast,
• a lump or enlarged lymph node in the armpit,
• skin or nipple retraction,
• bloody, spontaneous or one-sided nipple discharge,
• a change in the shape or size of one breast,
• an “orange peel” appearance of the skin,
• ulceration, crusting, scaling or a non-healing nipple lesion,
• redness, warmth or swelling of the breast that does not improve,
• a BI-RADS 4 or BI-RADS 5 result,
• a discrepancy between what the patient feels and what the imaging report describes.

The absence of pain does not exclude serious disease, and pain does not automatically mean cancer. The symptom simply needs to be explained.

Do you have an ultrasound or mammography result that concerns you?

Do not interpret it on your own. BI-RADS, the description of the lesion and a biopsy recommendation require calm discussion with a doctor. An imaging result is not yet a histopathological diagnosis.

Breast diagnostics at Wyspa Medycyny Przyjaznej in Gdańsk

At Wyspa Medycyny Przyjaznej, Iwona Chruścicka, MD, PhD, helps patients interpret ultrasound and mammography results, assess breast lumps, qualify for biopsy, discuss histopathology results and plan further treatment. A breast surgeon consultation can be particularly important when the patient receives a BI-RADS 4–5 result, a biopsy recommendation or a concerning description of a lesion.

The purpose of the consultation is not to frighten the patient, but to organise the situation: what is already known, what remains unknown, which test is needed and when a diagnosis can be expected. In many cases, further diagnostics confirm a benign lesion, but even then the diagnostic process should be completed responsibly — without guessing and without postponing important decisions.

Learn more about Dr Iwona Chruścicka Breast lump Surgery

What should you ask the doctor after ultrasound or mammography?

• What exactly does my BI-RADS category mean?
• Does the result require follow-up, another examination, biopsy or a breast surgeon consultation?
• Does the imaging finding correspond to the area where I can feel the lump?
• Do I have dense breasts and do I need ultrasound to complement mammography?
• Is the lesion a cyst, a solid lesion, microcalcifications or something indeterminate?
• Do I need fine-needle, core needle, vacuum-assisted or another type of biopsy?
• Which imaging method should be used to guide the biopsy?
• When will the histopathology result be available and who will discuss it with me?
• Can the lesion be safely observed, or should I act more quickly?
• When should I seek urgent care regardless of the scheduled follow-up date?

FAQ — breast ultrasound, mammography, BI-RADS and biopsy

Which is better: breast ultrasound or mammography?

There is no single answer. Mammography is the basis of screening in specific age groups, while ultrasound is important in younger patients, women with dense breasts, when a lump is present, or as a complementary examination.

Can breast ultrasound replace mammography?

It should not usually replace screening mammography in women covered by the programme. It may, however, be a very important complementary or diagnostic examination depending on symptoms and breast density.

When should mammography be performed?

In Poland, the breast cancer screening programme covers women aged 45–74, usually every 24 months, provided they meet the programme criteria. If symptoms are present, diagnostics should proceed independently of the screening programme.

When should breast ultrasound be performed?

Breast ultrasound is particularly useful in younger patients, when a lump is palpable, in women with dense breasts, in cysts, focal pain, follow-up of known lesions and as a complement to mammography.

Does BI-RADS 4 mean cancer?

Not always. BI-RADS 4 means a suspicious lesion that usually requires biopsy. Some such lesions prove benign, but this cannot be confirmed responsibly without examining tissue.

Does a biopsy referral mean that I have cancer?

No. Biopsy means that tissue needs to be collected for assessment. Many biopsies confirm benign lesions, but they are performed to obtain a reliable diagnosis and avoid delaying treatment if it is required.

Does a normal mammogram exclude breast cancer?

A normal mammogram is very important information, but it does not always end diagnostics if the patient has a concerning symptom. The doctor may recommend ultrasound, additional mammographic views, follow-up or biopsy.

Does a normal ultrasound exclude breast disease?

A normal ultrasound is usually reassuring, but if the patient continues to feel a lump or has another concerning symptom, the result should be discussed with a doctor and correlated with a clinical examination.

When should I see a breast surgeon?

A breast surgeon consultation is recommended in the case of a lump, BI-RADS 4–5, a biopsy recommendation, an unclear ultrasound or mammography result, a discrepancy between symptoms and imaging, or a histopathology result that requires discussion.

Who provides breast disease consultations at WMP?

On the WMP website, Iwona Chruścicka, MD, PhD, is described as a general and oncological surgeon with experience in the diagnosis and treatment of breast diseases, interpretation of ultrasound and mammography, breast tumour biopsy and assessment for surgical treatment.

Sources for medical and editorial verification

• Wyspa Medycyny Przyjaznej, Iwona Chruścicka, MD, PhD: https://www.wyspamedycynyprzyjaznej.pl/pl/dr-iwona-chruscicka
• Wyspa Medycyny Przyjaznej, breast lump — diagnostics, biopsy and treatment: https://www.wyspamedycynyprzyjaznej.pl/pl/guz-piersi
• Pacjent.gov.pl, breast cancer prevention: https://pacjent.gov.pl/program-profilaktyczny/profilaktyka-raka-piersi
• Pacjent.gov.pl, mammography — how to access it: https://pacjent.gov.pl/mammografia-jak-skorzystac
• NHS, tests and next steps for breast cancer in women: https://www.nhs.uk/conditions/breast-cancer-in-women/tests-and-next-steps-for-breast-cancer-in-women/
• American Cancer Society, breast density and mammogram report: https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/mammograms/breast-density-and-your-mammogram-report.html
• American Cancer Society, breast cancer screening recommendations: https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html
• National Cancer Institute, understanding breast changes: https://www.cancer.gov/types/breast/breast-changes
• Mayo Clinic, breast biopsy: https://www.mayoclinic.org/tests-procedures/breast-biopsy/about/pac-20384812
• StatPearls / NCBI Bookshelf, Breast Imaging Reporting and Data System: https://www.ncbi.nlm.nih.gov/books/NBK459169/
• Łukasiewicz E. et al., Fine-needle versus core-needle biopsy — which one to choose in preoperative assessment of focal lesions in the breasts?, PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC5769667/
• Google Search Central, Creating helpful, reliable, people-first content: https://developers.google.com/search/docs/fundamentals/creating-helpful-content
• Google Search Central, Article structured data: https://developers.google.com/search/docs/appearance/structured-data/article
• Google Search Quality Rater Guidelines: https://guidelines.raterhub.com/searchqualityevaluatorguidelines.pdf